ArticleScientific reports2026
Hybrid feature selection with novel deep learning model for COVID-19 risk prediction.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the past five years, the COVID-19 epidemic has created unparalleled difficulties throughout the world. The COVID-19 virus has not entirely disappeared all over the world, and it is still spreading with new transformations and new variants throughout the globe. Hence, the requirement of exact and appropriate risk prediction can emphasize the care of patients and effectively allocate the resources for improving their lifespan. The prediction of risk factors for COVID-19 is highly needed for minimizing these hazards. As a result, this work develops the Fuzzy-Deep Kronecker Network + Deep Recurrent Neural Network (Fuzzy-DKRNN)-based Covid-19 risk prediction model. The data normalization is the primary stage of this process. The log scaling is utilized to provide the normalized data effectually. For selecting the significant features, the hybrid similarity measure is employed. Moreover, the Fisher score with Pearson’s Correlation Coefficient (PCC) is considered as the hybrid similarity measure. The proposed Fuzzy-DKRNN model effectively performs the COVID-19 risk prediction. In addition, the accuracy, precision, recall, and F1-Score are utilized to validate the Fuzzy-DKRNN with the ideal values like 0.908, 0.900, 0.918, and 0.890 are attained.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.